Covid emergency: in Italy the contagion curve continues to be under strict control while the vaccination campaign continues at full speed. “There are 2,2 million doses of Pfizer vaccine that will be distributed starting tomorrow morning to the regions and autonomous provinces. The influx of the vaccine into Italy began today and will end tomorrow, when all direct deliveries to the more than 200 health facilities designated by the regions will start. Pfizer's batch is the largest ever among those procured since the start of the vaccination campaign ”. This was announced by the Covid emergency commissioner on general Francesco Figliuolo.
Meanwhile, the curve relating to the spread of the virus in our country is constantly monitored. According to data provided by the Ministry of Health, the new positive cases registered in the last 24 hours are 10.404 (yesterday 8.444). The new deaths are 373 (yesterday 301). The currently positives are instead 448.149, 4663 cheaper than yesterday; the discharged healed are 14.688 (yesterday 16.539). There are 302.734 molecular and antigenic buffers always carried out in the last 24 hours (yesterday 145.819). Covid patients admitted to intensive care are 2.748 while they still remain in home isolation 425.089 people infected with the virus.
Contagions under control and intensive vaccination
The minimum interval between the first and second dose of the Russian Sputnik V vaccine against the virus may be increased SARS-CoV-2. To give the news is Alexander Gintsburg, director of the Gamaleya research center in Moscow who developed it. "We believe that it is possible to increase the minimum interval between the first and second vaccine, from the previously approved 21 days, up to three months - explains the expert - The extension of the interval will not affect the immune response induced by the vaccine and , in some cases, it will strengthen and prolong it ”.
“This conclusion - underlines Gintsburg - derives from our experience in the use of vaccines using the same adenovirus platform. And, above all, from successful mass vaccination campaigns conducted in Russia and in numerous other countries ”. For the director of Gamaleya, “this decision would significantly accelerate“ the immunization campaigns ”. Gintsburg concludes. "We believe it is up to each national regulatory agency to decide whether to maintain the 21-day interval between doses or extend it to 3 months.".
